Aspira Women's Health appoints John Strahley as CFO; Brian Hungerford departs

Aspira Women's Health Inc.

Brian Hungerford's consulting agreement terminated at his request effective April 26, 2026, for personal reasons.
John Strahley appointed CFO and CAO effective April 27, 2026; fractional role requiring minimum 20 hours per week.
Strahley receives annual base salary of $167,000 and grant of 70,000 stock options; 25% vest after 90 days.
Strahley previously served as CFO of IsoPlexis and Managing Director at Ironwood Capital; began career as CPA.
No severance or post-termination benefits beyond accrued obligations; employment at-will.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brian Hungerford

Chief Financial Officer

AWHL · Aspira Women's Health Inc.

Effective: 2026-04-26
Successor: John Strahley
Filed: April 30, 2026, 7:59 PM ET

On April 26, 2026, the consulting agreement between the Company and Hungerford Consulting LLC, under which Brian Hungerford had served as Chief Financial Officer, terminated at the request of Hungerford Consulting LLC.

Appointed

John Strahley

Chief Financial Officer and Chief Accounting Officer

AWHL · Aspira Women's Health Inc.

Effective: 2026-04-27
Filed: April 30, 2026, 7:59 PM ET

On April 26, 2026, Aspira Women's Health, Inc. (the "Company") appointed John Strahley as Chief Financial Officer and Chief Accounting Officer of the Company, effective April 27, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian Hungerford departed as Chief Financial Officer at Aspira Women's Health Inc..

Action: departed
Role: Chief Financial Officer

Exact text from the filing

On April 26, 2026, the consulting agreement between the Company and Hungerford Consulting LLC, under which Brian Hungerford had served as Chief Financial Officer, terminated at the request of Hungerford Consulting LLC.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

John Strahley was appointed as Chief Financial Officer and Chief Accounting Officer at Aspira Women's Health Inc..

Action: appointed
Role: Chief Financial Officer and Chief Accounting Officer

Exact text from the filing

On April 26, 2026, Aspira Women's Health, Inc. (the "Company") appointed John Strahley as Chief Financial Officer and Chief Accounting Officer of the Company, effective April 27, 2026.

View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0000926617-26-000029

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.